Ken Griffin
YTEN

Ken Griffin’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

Ken Griffin’s Portfolio YTEN Stock Details YTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Hold
0
– -$1K – 8387
2014
Q1 		– Hold
0
– – – 7776

Other funds holding YTEN

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
CS
Cannell & Spears New York $5.62B AUM 41.25% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
CCB
Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GWM
Grand Wealth Management Grand Rapids, Michigan $240M AUM 21.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Ken Griffin's YTEN Position: Q1 2024 in Review

Ken Griffin sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q1 2024, closing a stake of 421 shares — an estimated $2.42K sold.

Ken Griffin first reported a position in YTEN in Q1 2014 and held it in 12 quarters. The position peaked at $49K in Q1 2019. 19 funds tracked by Wall St. Rank hold YTEN as of Q1 2024.

  • Ken Griffin reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Ken Griffin sold 421 Yield10 Bioscience, Inc. Common Stock shares in Q1 2024, an estimated $2.42K.
  • Ken Griffin first reported a position in Yield10 Bioscience, Inc. Common Stock in Q1 2014 and held it in 12 quarters.
  • Ken Griffin's Yield10 Bioscience, Inc. Common Stock position peaked at $49K in Q1 2019.
  • 19 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q1 2024.

Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.